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ABSTRACT
Mild Cognitive Impairment (MCI) is a syndrome thought to fall between
cognitively normal aging and dementia. Although much research has investigated the
structural neuroimaging correlates of amnestic MCI, little research has been done on the
imaging correlates of non-amnestic MCI. Even less research has examined the anterior
cingulate cortex (ACC), a region important in executive functions (EFs), in these
patients. This study attempted to address this gap by examining hippocampal and ACC
volumes among amnestic and non-amnestic MCI patients and cognitively normal
controls. Those with amnestic MCI were expected to have smaller hippocampal volumes
than controls and those with non-amnestic MCI, while those with non-amnestic MCI
were expected to have smaller ACC volumes than controls or those with amnestic MCI.
Fifty-seven participants, 21 cognitively normal controls, 20 with amnestic MCI, and 16
with non-amnestic MCI, were recruited. Contrary to hypotheses, mixed-model analyses
of variance revealed no significant differences among the diagnostic groups in ACC or
hippocampal volumes. These results suggest that the ACC is not involved in MCI or that
it is affected only in later disease stages. The executive dysfunction seen in some cases of
non-amnestic MCI may be due to atrophy in other brain regions associated with EF or
may be due to white matter changes in these regions. However, the study’s small, highly
educated sample and the possibility that amnestic MCI patients also exhibited executive

viii

dysfunction may also have impacted results. Future research should longitudinally
examine MCI patients with and without executive dysfunction to determine the role of
the ACC and other brain regions involved in EF and should also investigate the
correlation between neuropsychological test scores and volumes in these brain regions.
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CHAPTER ONE
INTRODUCTION

Mild Cognitive Impairment (MCI) is a concept initially created to identify
patients who were experiencing cognitive impairments consistent with, but not fully
qualifying for, a diagnosis of dementia (Petersen & Morris, 2005). Although functioning
fairly well, these patients were often found to be at increased risk of developing
dementia, particularly Alzheimer’s disease (AD) (Davis & Rockwood, 2004; Petersen &
Morris, 2005; Petersen & O’Brien, 2006). The development of the concept of MCI
allowed researchers the opportunity to identify possible AD patients before they became
demented (Davis & Rockwood, 2004; Petersen & O’Brien, 2006; Winblad et al., 2004).
Because of its close link with AD, MCI was characterized as primarily amnestic,
involving memory loss not accounted for by simple aging, while functional skills and
general cognitive abilities remain intact (Davis & Rockwood, 2004; Rosenberg &
Lyketsos, 2008; Winblad et al., 2004).
Over the years, the concept of MCI has evolved to include cognitive deficits
beyond the memory domain, including executive dysfunction, language, and visuospatial
impairments (Petersen, 2004; Winblad et al., 2004). The expansion of the concept of
MCI to include these non-amnestic categories allowed clinicians and researchers to
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identify a wider range of at-risk patients. In fact, research has shown that some patients
who eventually go on to develop AD may initially experience non-memory deficits in the
absence of memory loss (Storandt, Grant, Miller, & Morris, 2006). In addition, some
researchers have posited that the non-amnestic category of MCI may include prodromes
of other forms of dementia, including Frontotemporal Dementia (FTD), dementia with
Lewy Bodies, and Vascular dementia (Busse, Hensel, Hugne, Angermeyer, & RiedelHeller, 2006; Petersen, 2004; Yaffe, Petersen, Lindquist, Kramer, & Miller, 2006).
Since the revision of the diagnostic criteria for MCI, much research has attempted
to elucidate the relationship between the amnestic and non-amnestic categories as well as
their relation to different forms of dementia. Studies have overwhelmingly supported the
link between amnestic MCI and Alzheimer’s disease, finding that amnestic MCI patients
may convert to AD at a rate of 16-41% per year (Gauthier et al., 2006). This is in stark
comparison to the much smaller conversion rate of 1-2% per year in the general
population (Petersen et al., 2001). In contrast, studies on non-amnestic MCI have been
less clear-cut. Some have found no difference from amnestic MCI in the rate of
conversion to AD (e.g., Fischer et al., 2007; Loewenstein et al., 2006), while others have
found that patients with non-amnestic MCI are more likely to convert to other forms of
dementia than their amnestic counterparts (e.g., Busse et al., 2006; Yaffe et al., 2006).
Moreover, research comparing the two subtypes has found several differentiating
factors beyond domains of impairment. As previously mentioned, some studies have
found the two subtypes to convert to different types of dementia at varying rates (Busse
et al., 2006; Yaffe et al., 2006). Studies on biological markers have also found that those
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with the amnestic type are more likely to have the APOE ε4 allele, a variant of a gene
consistently associated with an increased risk for the development of AD (Manly, BellMcGinty, Tangy, Schupf, Stern, & Mayeux, 2005). Additionally, the rate of reversion
back to “normal” cognition and, as a result, the stability of the diagnostic category, has
been found to vary by subtype (Busse et al., 2006; Jak et al., 2009; Loewenstein,
Acevedo, Agron, & Duara, 2007). Jak et al. (2009), in a study comparing clinical
outcomes of populations identified by different sets of diagnostic criteria for MCI, found
that the non-amnestic subtype was the most unstable diagnosis, with more patients
reverting back to normal than in any other category. Despite the abundance of research
on amnestic and non-amnestic MCI, it is still unclear whether these subtypes
preferentially lead to different forms of dementia, and what causes some to revert to
normal, remain cognitively stable, or convert to dementia.
In an attempt to address some of these inconsistencies in the literature, researchers
have frequently used structural and functional neuroimaging to explore the anatomical
and functional substrates of the subtypes of MCI. Not surprisingly, structural MRI studies
have frequently found that patients with amnestic MCI exhibit atrophy in medial
temporal lobe regions, primarily the hippocampus and entorhinal cortex (e.g., Becker et
al., 2006; Bell-McGinty et al., 2005; Caffarra, Ghetti, Concari, & Venneri, 2008; Jack et
al., 2004; Pa et al., 2009; Pennanen et al., 2005; Stoub et al., 2006; Whitwell et al., 2007).
These brain areas belong to the limbic system, and are known to be one of the main
processing sites for memory encoding within the brain.
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Importantly, hippocampal and entorhinal cortex atrophy are characteristically
associated with AD progression. In fact, medial temporal lobe structures are the first to
experience cell death in AD, presumably through the effects of neurofibrillary tangles
and amyloid plaques (Mesulam, 2000). These neuropathologies, which are required for a
definitive diagnosis of AD, form within and around neurons and disrupt their functioning,
leading to disruptions in cell-cell communication and eventual neuron death.
Consequently, hippocampal atrophy has been shown to be a harbinger of cognitive
decline in those with AD as well as MCI (Bell-McGinty et al., 2005; Jack et al., 2004;
Karas et al., 2008).
Functional neuroimaging studies have supported the conclusions reached through
structural imaging. Several researchers, using functional MRI, have found those with
amnestic MCI to exhibit reduced activity in hippocampal and entorhinal regions
(Johnson, 2004; Johnson et al., 2006; Machulda et al, 2003; Petrella et al., 2006; Small et
al., 1999). Such reduction in activity presumably indicates a decrease in neuronal
functioning within the affected regions compared to cognitively normal controls. This
decrease is most likely due to the neuronal damage and death caused by AD-related
neuropathologies. In support, functional imaging studies have found similar activity
reductions in medial temporal lobe regions in patients with AD. However, other research
has indicated that patients with MCI may actually exhibit increased activation than
controls in medial temporal lobe areas, including the hippocampus (see Pihlajamaki,
Jauhiainen, & Soininen, 2009, and Ries et al., 2008 for reviews). Researchers have
conceptualized these discrepant findings as evidence for a compensatory response, in
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which patients with MCI recruit more brain areas in order to counteract the effects of
early memory loss (Ries et al., 2008).
Imaging studies with non-amnestic MCI patients are not as common as those with
amnestic patients. However, of those that have been completed, the non-amnestic subtype
has frequently been found to be associated with atrophy and reduced metabolism in
several frontal and temporal lobe regions, including the anterior cingulate and
hippocampus (Caffarra et al., 2008; Jauhiainen et al., 2008; Johnson, Vogt, Kim, Cotman,
& Head, 2004; Machulda et al., 2009; Nobili et al., 2008; Pa et al., 2009; Whitwell et al.,
2007). Frontal lobe regions of the brain have been found to be associated with executive
functions, including the ability to plan, organize, direct and sustain attention, inhibit
unwanted behavior, and mentally shift between mindsets. The involvement of these
regions in patients with non-amnestic MCI is presumably associated with their functional
deficits. For non-amnestic patients suffering from executive dysfunction, for example, the
executive skills in which they are impaired are also those that are subserved by frontal
lobe regions.
The anterior cingulate cortex (ACC) in particular, a structure located in the medial
prefrontal cortex, is believed to be generally involved in executive functioning (Carter,
2000; Koo et al., 2008; Mesulam, 2000; Rosen et al., 2005). The ACC has commonly
been subdivided into subcallosal, rostral, and dorsal subregions, each with its own
specialization. Studies have found the subcallosal region to be involved in mood (Koo et
al., 2008) while the rostral region is implicated in affective regulation (Bush, 2000) and
the dorsal region in attention and executive control (Koo et al., 2008). Despite its

6
relevance, very few studies have investigated the ACC in MCI patients. Of those that did
pursue this line of research, they found evidence of atrophy or reduced metabolism in this
region in patients with non-amnestic MCI, coinciding with the patients’ cognitive deficits
(Caffarra et al., 2008; Jauhiainen et al., 2008; Johnson, et al., 2004).
Although studies have independently examined the neuroanatomical substrates of
amnestic and non-amnestic MCI, few studies have attempted to compare the regional
volumes of patients with each subtype. Those that have examined this question have
reported discrepant findings. Moreover, despite its relevance due to the impairments
associated with each subtype, no study to date has compared ACC and hippocampal
volumes in amnestic and non-amnestic MCI patients. The purpose of this study is to
address this gap in the literature by comparing the volumes of two manually outlined
regions of interest (ROIs), the ACC, divided into rostral and dorsal subregions, and the
hippocampus, among amnestic and non-amnestic MCI patients and cognitively normal
controls.

CHAPTER TWO
REVIEW OF RELATED LITERATURE

Historical Perspectives on MCI
Original Conceptualization and Diagnostic Criteria
The concept of Mild Cognitive Impairment (MCI) was first created in the 1980’s
by Petersen and colleagues (Petersen & Morris, 2005). MCI is a syndrome originally
conceptualized as a risk factor for the later development of Alzheimer’s disease (AD)
(Davis & Rockwood, 2004). Alzheimer’s disease is a progressive disease that is usually
first diagnosed in those age 65 and above (Mesulam, 2000). The hallmark symptom of
AD is memory loss, which usually begins as a decline in short-term episodic memory,
with relative preservation of remote episodic memories and semantic memory (Mesulam,
2000). As the disease progresses, however, even remote memories are prone to decay,
and the ability to create new memories is severely impaired (Mesulam, 2000). Other
cognitive domains, including language and visuospatial abilities, are also affected in later
stages of the illness (Mesulam, 2000). As a large percentage of the population reaches
older ages, it becomes important to identify AD as early as possible, in order to
implement treatments in initial stages of the illness. Thus, if MCI truly is a prodromal
stage of AD, MCI patients may represent a useful target population for preventative
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treatments for AD. This aspect of MCI has made it one of the most widely studied
models of cognitive decline.
Following its close ties to AD, MCI was historically thought of as an amnestic
syndrome, characterized by progressive memory loss in the absence of functional
impairments or general cognitive decline. Petersen (e.g., Petersen, Smith, & Waring,
1999) first proposed formal diagnostic criteria for MCI, which required a subjective
memory complaint usually elicited during a clinical interview, along with intact general
cognitive functioning. This has been operationalized in several different ways, most
commonly as a score greater than 24 on the Mini Mental State Exam (MMSE) (Storandt
et al., 2006). In addition to a subjective memory complaint, objective memory
impairment must also be observed through neuropsychological testing. Although varied
in the literature, this is usually operationalized as a score greater than 1.5 standard
deviations below age and education-based norms on a test of delayed recall (Storandt et
al., 2006). Despite memory deficits, to be diagnosed with MCI according to Petersen’s
criteria a person must exhibit preserved ability to perform activities of daily living,
usually defined as scores less than 1 on all 6 domains of the Clinical Dementia Rating
Scale (CDR) (Storandt et al., 2006). Finally, a person with MCI cannot also be diagnosed
with dementia. To ensure this, MCI patients are usually required to achieve a Global
CDR score less than one (Storandt et al., 2006).
Although the clinical interview is frequently used in making an MCI diagnosis,
clinicians and researchers also utilize alternative methods to supplement clinician
judgment when assessing for possible MCI (Gauthier et al., 2006; Petersen et al., 2001).
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Neuropsychological testing is a valuable tool for diagnosis, as its sensitivity allows the
clinician to detect possible cases of MCI before behavioral or functional deficits are
apparent (Petersen et al., 2001). However, because of individual differences in cognitive
performance and MCI presentation, a diagnosis cannot be based upon testing information
alone, and clinical judgment including consideration of the patient’s history and
symptomatology is always necessary (Petersen et al., 2001).
Structural and functional neuroimaging may also be used to assist the clinician in
detecting cases of MCI. Structural magnetic resonance imaging (MRI) has shown that
atrophy in the hippocampus, a structure located in the limbic area of the brain and
integral for memory (Mesulam, 2000), can predict progression from cognitively intact to
a diagnosis of MCI, and from MCI to AD (Bell-McGinty et al., 2005; Jack et al., 2004;
Karas et al., 2008; Petersen et al., 2001). In addition, studies have found that atrophy in
the entorhinal cortex, which is adjacent to and extensively interconnected with the
hippocampus (Mesulam, 2000), can predict conversion of MCI to AD, perhaps beyond
the ability of hippocampal atrophy to do so (de Toldedo-Morrell et al., 2004; Petersen et
al., 2001; Stoub et al., 2005). The utility of assessing entorhinal cortical atrophy is still
under debate, however, as other studies have not found any additional diagnostic
sensitivity contributed by entorhinal cortex imaging beyond that gained from measuring
hippocampal volumes (Jack et al., 2005; Stoub et al., 2006).
Similarly, functional neuroimaging may be useful for the diagnosis of MCI.
Research has shown that those with this diagnosis exhibit reduced activation in the
posterior cingulate and temporoparietal regions of the brain (Petersen et al., 2001). Yet,
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as with the use of neuropsychological test batteries, a diagnosis of MCI cannot be made
with neuroimaging data alone, particularly because the atrophy and activity reductions
associated with MCI may also be found in other cognitive disorders (Petersen et al.,
2001).
Initially, some researchers questioned whether MCI was not equivalent to a single
score on a clinical rating scale like the CDR. Some did indeed propose that MCI was
synonymous with a CDR score of 0.5, which represents questionable dementia. However,
research has shown that MCI diagnostic criteria and the criteria to reach a score of 0.5 on
the CDR identify different patient populations (Petersen et al., 2001). Similarly, although
a score of two on the Global Deterioration Scale (GDS) represents a person who is
cognitively normal but with subjective memory complaints, a description that may fit
well with MCI diagnostic criteria, research has shown that MCI patients are not reliably
identified by this category, and may receive GDS scores of 2 or 3, representing mild
dementia (Petersen et al., 2001). Such research has shown that, although clinical rating
scales are important tools for gauging a person’s cognitive abilities, there is no direct
agreement between a person’s score and an MCI diagnosis.
Early Research
MCI is thought to be a pathological process distinct from normal aging
(Knopman, Boeve, & Petersen, 2003; Petersen, 2006; Petersen et al., 2001). In support,
patients who die with a diagnosis of MCI, when autopsied, have been found to manifest
neuropathologies associated with dementia, such as neurofibrillary tangles and amyloid
plaques in the medial temporal lobe (Geda et al., 2006; Petersen, 2006; Petersen et al.,
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2001). Although these pathologies may also be found in normal aging, the degree to
which they occur in MCI patients is more extensive than that due to age-related changes.
Furthermore, studies on normal aging have indicated that, although slight
cognitive decline may occur with aging, this decline is a result of physiological aging
instead of a pathological disease process (Petersen et al., 2001). In fact, some research
has shown that once those with incipient dementia are removed from a sample of those
experiencing normal aging, the remainder of the sample does not exhibit cognitive
decline in areas such as delayed recall (Knopman et al., 2003). Despite this finding, much
research has suggested that aging is associated with some cognitive decline, and that the
memory loss most commonly associated with aging is in rote, short term recall, of the
kind assessed by a test of Digit Span (Knopman et al., 2003). This is similar to the pattern
of memory loss experienced in patients with MCI. However, as opposed to MCI patients,
when allowed sufficient time to learn the material, older adults have been found to be just
as capable of recalling the learned material as their younger counterparts (Knopman et
al., 2003).
Research has also indicated that, even among elderly experiencing age-related
cognitive decline, the progression to AD is no different than in the older adult population
without cognitive deficits (Petersen et al., 2001). In contrast, those with MCI have been
shown to progress to AD at elevated rates compared to the general population as well as
those who are normally aging while suffering from cognitive deficits (Petersen et al.,
2001). However, other research has suggested that older adults with age-related cognitive
decline may in fact progress to dementia at a higher rate than in healthy, cognitively
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intact populations (Petersen et al., 2001). It is therefore unclear whether cognitive
decline, including the development of memory impairment, is intrinsic to aging. Despite
this, research has generally supported the assertion that MCI is not an extension of
normal aging, and is instead a distinct, pathological process.
Early research on MCI determined that those with this diagnosis progressed to
AD at rates of 10-15% per year, much higher than the 1-2% annual progression rate in
the general population (Petersen et al., 2001). Moreover, research by the Mayo
Alzheimer’s Disease Research Center in Rochester, MN, reported that 80% of a sample
of patients with MCI converted to AD over a 6-year period (Petersen et al., 2001).
Conversely, later studies indicated that not all patients diagnosed with MCI exhibited the
same trajectory of decline, and many converted to dementias other than that of the
Alzheimer type (Petersen et al., 2001).
Discoveries such as these have led researchers to acknowledge MCI as a highly
heterogeneous category; some with the diagnosis convert to AD, some to other forms of
dementia, while others remain stable or actually improve (Busse et al., 2006; Jak et al.,
2009; Knopman et al., 2003; Loewenstein et al., 2006; Petersen et al., 2001; Winblad et
al., 2004). Although differences in research methodology and diagnostic criteria likely
contribute to this heterogeneity, it also appears that MCI may constitute a population of
individuals with diverse pathologies (Petersen et al., 2001). In fact, studies have shown
that, despite the exclusive emphasis on memory impairment in early conceptualizations
of MCI, MCI patients with isolated memory impairments are rare. It is much more
common to see patients with multiple domains of impairment (Nordlund et al., 2005).
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Current Perspectives on MCI and Revision of Diagnostic Criteria
Despite earlier conceptualizations of MCI emphasizing memory loss and
association with AD, later research has revealed not only that other non-memory
cognitive domains may be impaired in MCI, but also that the clinical outcome of MCI
was heterogeneous and included dementias beyond AD. Spurred by such research and in
order to clarify the construct of MCI, the International Working Group on Mild Cognitive
Impairment convened and modified the diagnostic criteria for MCI (Petersen, 2004;
Winblad et al., 2004).
The working group acknowledged that MCI represented a heterogeneous
category, particularly in symptomatology (Winblad et al., 2004). Research has found that
symptoms of MCI may extend beyond memory into other cognitive domains and that a
person may have more than one type of impairment. Thus, the construct of MCI could
include either a primary memory impairment, a memory impairment accompanied by
non-memory impairments, or decline in a non-memory domain, such as executive
functioning, language, or visuospatial skills. The working group also noted the findings
of recent studies suggesting etiological heterogeneity of the MCI population. Based on
such findings, the working group concluded that the symptoms associated with MCI may
be due to AD, but may also be due to other neurodegenerative disorders such as
Parkinson’s disease or Frontotemporal Dementia. Additionally, MCI could be due to
other problems, such as vascular disease or psychiatric disorders (Winblad et al., 2004).
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In the context of these advances in the knowledge concerning MCI, the working
group proposed several recommendations, including the need to adapt the diagnostic
criteria of MCI to address current research findings. The proposed criteria allowed for
four specific diagnoses within the MCI population: amnestic, single domain; amnestic,
multiple domain; non-amnestic, single domain; and non-amnestic, multiple domain. Such
revisions would allow prodromal AD patients with non-amnestic impairments to be
identified, as well as patients suffering from the early stages of a non-AD dementia
(Winblad et al., 2004).
The working group’s recommendation for the revised general criteria for a
diagnosis of MCI required that the patient not be cognitively normal. This should be
decided through the use of clinical judgment on the part of the clinician, along with
evidence of cognitive abnormality from the MMSE. However, despite cognitive
abnormality, the patient cannot meet DSM-IV or ICD-10 criteria for dementia.
Additionally, there must be evidence of cognitive decline; a person with longstanding
cognitive deficits, such as those with Mental Retardation or Traumatic Brain Injury,
would therefore not qualify for a diagnosis of MCI. Whatever cognitive deficits the
patient experiences should be a decline from a higher level of previous functioning. This
should be gathered from a detailed history taken from the patient, and preferably
corroborated by another source. Cognitive decline, as well as significant impairment in
one or more cognitive domains as compared to age-adjusted norms, should also be
supported by objective neuropsychological assessment. Furthermore, the revised criteria
required that the patient not exhibit significant functional impairment in activities of daily
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living. However, as opposed to early criteria which did not allow evidence of any
functional deficits, the working group’s revised criteria recognized that those with MCI
may show minor impairment in complex tasks (Winblad et al., 2004). In fact, recent
research has shown that patients with well-defined MCI exhibited slight impairment in
complex tasks requiring memory and executive functions, although they still maintained
the ability to function independently (Rosenberg & Lyketsos, 2008).
Once the probable diagnosis of MCI has been determined, the specific MCI
subtype of the patient should be assessed through neuropsychological testing. Although
no specific assessments have been recommended for MCI subtype diagnosis, at least one
form of delayed recall is commonly used to assess for memory impairment (Jak et al.,
2009). Neuropsychological testing would also be used to assess other cognitive domains,
such as visuospatial, executive function, and language domains. Although no universally
accepted cut-off exists (Jak et al., 2009), performance 1.5-2.0 standard deviations below
age- and education-adjusted norms is commonly required for a determination of the
“significant” impairment required for a diagnosis of MCI. If the patient is only impaired
in the memory domain, they would be diagnosed with amnestic MCI, single domain,
while a patient with a primary impairment in memory as well as deficits in other domains
would receive the diagnosis of amnestic MCI, multiple domain. Similarly, a patient
exhibiting impairment in a non-memory domain alone would be diagnosed with nonamnestic MCI, single domain, while a patient impaired in multiple non-amnestic domains
would be diagnosed with non-amnestic MCI, multiple domain.
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Several studies have examined the implications of the revised diagnostic criteria
for identification of patient populations. Storandt et al. (2006) conducted a study
examining differences in clinical outcome among patients diagnosed according to the
original criteria, which identified patients with amnestic MCI, the revised criteria, which
identified those with memory deficits as well as non-memory impairments, and patients
that did not yet meet criteria for MCI (termed pre-MCI) (Storandt et al., 2006). All
patients had a CDR rating of 0.5 at the beginning of the study, and all patients, along with
a collateral source, were given a semi-structured interview. The original MCI criteria
operationalized an objective memory impairment by requiring patients to score at least
1.5 standard deviations below the mean for the reference group on the Logical Memory
subtest of the Wechsler Memory Scale (WMS). In contrast, the revised criteria assessed
objective cognitive deficits in three areas. Memory was assessed using the Information
subscale from the Wechsler Adult Intelligence Scale (WAIS), the Associate Learning and
Logical Memory subscales from the WMS, and the Boston Naming Test. Visuospatial
abilities were assessed using the Block Design and Digit Symbol subscales from the
WAIS and Trailmaking Test A. Executive functions were measured using the Mental
Control and Digit Span Forward subscales of the WMS and Word Fluency using the
letters S and P. Similar to the cut-off scores used with the original criteria, objective
impairment was defined as performance of at least 1.5 standard deviations below the
performance of an age-adjusted reference group. Finally, the pre-MCI group was
identified primarily by clinician judgment using the interview. The group had a CDR
score of 0.5, but did not meet either set of criteria for MCI (Storandt et al., 2006).
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As expected, the two sets of diagnostic criteria identified dissimilar MCI
populations. The original criteria identified 32 patients from the sample as having MCI,
while the revised criteria identified 90 patients from the same sample as having MCI.
Despite differences in the size of the identified populations, both the samples declined at
comparable, elevated rates compared to those with pre-MCI. The patients identified by
the original criteria had elevated decline on measures of general cognitive functioning,
memory, visuospatial abilities, and executive functions. Interestingly, the group
diagnosed according to the revised criteria declined at an elevated rate for all the above
measures except executive functions, for which there was no difference between the MCI
and pre-MCI groups. Moreover, the time for both groups to advance to a CDR rating of 1
was comparable, and both of the groups took nearly half the time to advance to this point
as the pre-MCI group (Storandt et al., 2006).
Of those patients who could be examined for neuropathological evidence of
dementia at autopsy, 100% of the patients in the original criteria group had
neuropathological AD. In contrast, 90% of the revised criteria group had confirmed AD,
with one patient having hippocampal sclerosis without AD, and another having vascular
dementia and Lewy Body disease without AD. Ninety-one percetn of those from the preMCI group had AD, while three were neuropathologically normal, and one had
corticobasal degeneration (Storandt et al., 2006).
Thus, this study provides evidence that although slight differences may exist
between samples identified by the original and revised MCI criteria, several similarities
between the groups are also prominent. In addition, this study revealed that AD can begin
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with deficits in non-memory domains, as several of those with non-amnestic MCI were
found to have confirmed AD upon autopsy. This finding supports the revision of
diagnostic criteria to allow for non-amnestic subtypes, which may allow identification of
those with prodromal AD who do not initially present with the typical array of memory
deficits. Finally, because more patients in the sample identified by the revised criteria
converted to non-AD pathologies than those identified by the original, amnestic MCI
criteria, it may be that non-amnestic subtypes can also represent prodromal stages for
non-Alzheimer’s dementias (Storandt et al., 2006).
However, the findings of Storandt et al. (2006) may have been affected by several
factors related to criteria operationalization known to affect the outcome of MCI samples.
Indeed, despite the recommendation of the working group for a reconstruction of MCI
diagnostic criteria, much variability still exists in the operationalization of the criteria in
research on MCI (Jak et al., 2009; Petersen & Morris, 2005). A universally accepted cutoff score necessary for an MCI diagnosis has not been agreed upon, and research
protocols have used cut-points ranging from 1.0-2.0 standard deviations below ageadjusted norms (Jak et al., 2009). Petersen and Morris (2005) noted that this
inconsistency in the use of cut-off scores as well as the emphasis on cut-offs instead of
the use of clinical judgment may have contributed to the instability occasionally found
with the MCI diagnosis (Petersen & Morris, 2005).
Additionally, the number and type of neuropsychological assessments used for
objective corroboration of cognitive decline have varied considerably in the literature
(Jak et al., 2009; Petersen & Morris, 2005). Not only do such inconsistencies prevent
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clear comparisons from being drawn across research studies, but research has also shown
that the use of different criteria leads to the identification of patient populations that differ
in size and clinical outcome (Jak et al., 2009). These factors may have influenced the
results of the study by Storandt et al. (2006), which used a strict cut-off score of 1.5
standard deviations and required only one abnormal score for diagnosis.
Jak et al. (2009) further explored the effect of varied diagnostic criteria on the
composition and outcome of MCI samples, taking into account the use of different cut-off
scores and number and type of assessments required for diagnosis. The study compared
the clinical outcomes of populations identified by different sets of MCI criteria and
provided evidence for the importance of using multiple neuropsychological measures
when assessing for MCI.
Several sets of diagnostic criteria were compared. The “historical criteria” set
identified patients as having amnestic MCI if they performed 1.5 standard deviations
below age-based norms on the Logical Memory subtest of the WMS-R. The “typical
criteria” set identified those with MCI who scored more than 1.5 standard deviations
below age-based norms in any cognitive domain, including memory. The
“comprehensive criteria” diagnosed with MCI those who scored more than one standard
deviation below age-based norms on two or more subtests assessing a single cognitive
domain. The “liberal criteria” identified MCI in those who scored more than one standard
deviation below age-based norms on a single test per cognitive domain. Finally, the
“conservative criteria” diagnosed with MCI those who performed more than 1.5 standard
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deviations below age-based norms on two or more tests within one cognitive domain (Jak
et al., 2009).
Similar to the findings of Storandt et al (2006), the size of patient samples
identified by the different criteria sets varied greatly; 10-74% of the entire sample was
diagnosed with MCI depending on the criteria used. Prevalence rates of single-domain
amnestic MCI in the sample varied from 8.9-12.2%, rates for non-amnestic single domain
MCI varied from 2.2-31.1%, rates for multiple domain amnestic MCI ranged from 1.123.3%, and those for multiple-domain non-amnestic MCI varied from 0-10%. Moreover,
agreement in diagnosis across the criteria sets ranged from 36-94% of the patient sample
(Jak et al., 2009).
The stability of patients’ diagnoses also depended on which criteria were used.
Seventy to ninety-eight percent of the identified samples maintained their diagnosis over
an average of 17 months. While the historical criteria exhibited the most diagnostic
stability, the comprehensive criteria exhibited the least stability. Although conversion
from normal to MCI contributed to this instability, many patients also reverted from an
MCI diagnosis to normal (Jak et al., 2009).
Additionally, although assessment for memory impairment has been typically
confined to verbal memory, Jak et al. (2009) demonstrated the importance of assessing
other forms of memory, such as visual memory, as well. This provided a more sensitive
assessment for MCI than a measurement of verbal memory alone. Indeed, the historical
criteria, which used only a measure of verbal memory, was found to overlook patients
who qualified for the diagnosis due to visual memory impairments in the absence of
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deficits in verbal memory. Other studies have also found that the inclusion of visual
memory measures allowed the diagnosis of patients with MCI who would have been
missed had only verbal memory measures been used (Petersen, 2004).
In addition, in both memory and non-memory domains, the sensitivity and
specificity of the MCI diagnosis was improved if impairment in two assessments within
one cognitive domain was required for diagnosis. The use of this requirement also
increased diagnostic stability over time. This supports assertions by Petersen and O’Brien
(2006) and Petersen and Morris (2005) that studies’ use of a diagnostic criterion which
requires impairment on only one assessment for diagnosis may have contributed to the
elevated rates of reversion to normalcy observed in the literature.
These findings suggest that operationalization of criteria is an important
consideration for both researchers and clinicians, in that it strongly influences the
sensitivity of the diagnosis as well as its stability over time. Importantly, Jak et al. (2009)
also demonstrated that the revised diagnostic criteria for MCI, which included nonmemory domains, allowed for the identification of a larger number of patients at risk for
the development of MCI.
Subtypes of MCI
Amnestic MCI
Amnestic MCI is a syndrome characterized by a memory performance below that
expected for one’s age and education. The prevalence of amnestic MCI, including both
multiple and single domains, has been found to range from 3 to 6% (Rosenberg &
Lyketsos, 2008). More specifically, in a sample of adults age 75 and older, single domain
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amnestic MCI was found in 4.5% of the sample, while multiple domain amnestic MCI
was found in 5.5% of the sample (Busse et al., 2006). Although reversion to normal has
been found to occur in all MCI subtypes, the rate of reversion has been found to be
lowest in amnestic MCI, while the rate of conversion to AD has been
found to be the highest among those with this subtype (Rosenberg & Lyketsos, 2008).
Those with amnestic MCI have been found to convert to AD at rates ranging from 1641% per year (Gauthier et al., 2006).
Several factors have been found to predict conversion to dementia, including
being a carrier for the ε4 allele of the gene coding for apolipoprotein E, poor performance
on verbal-based delayed recall tasks and executive functioning tasks, particularly when
the patient is unaware of such deficits, poor baseline verbal memory, informant reports of
cognitive decline, psychiatric symptoms, such as depression, and the presence of
functional impairment (Gauthier et al., 2006; Petersen & O’Brien, 2006; Rosenberg &
Lyketsos, 2008).
Studies have shown the APOE ε4 allele to be more often found in those with
amnestic MCI than in other MCI subtypes (Manly et al., 2005). Because the ε4 allele is
known to be a risk factor for AD, its prevalence in those with amnestic MCI suggests that
this, more than other MCI subtypes, may be an early stage of Alzheimer’s disease. To
investigate this possibility, neuropathological studies of amnestic MCI have compared
the amount and type of brain abnormalities in those with amnestic MCI and AD.
AD is associated with certain neuropathological features termed neurofibrillary
tangles (NFTs) and amyloid plaques. Neurofibrillary tangles consist of intra-neuronal
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aggregations of a phosphorylated form of tau, a protein involved in the cytoskeletal
functioning of the neuron. Amyloid plaques occur when β-amyloid, a peptide involved in
neuronal functioning, aggregates outside of neurons (Mesulam, 2000). Both of these
neuropathologies disrupt neuronal functioning and eventually lead to cell death. Although
initially focused in the medial temporal lobes of the brain, an area integral for memory
function, these abnormalities eventually spread throughout the brain, with the exception
of a few areas associated with motor and sensory function (Mesulam, 2000).
Studies have found that, upon autopsy, most of those with amnestic MCI did not
meet neuropathological criteria for AD (Petersen et al., 2006). However, compared to
those who died with a diagnosis of probable AD and those who died while cognitively
normal, those with MCI had an intermediate amount of brain abnormalities, including
NFTs and amyloid plaques. This was particularly salient in the medial temporal lobes
(Petersen et al., 2006). This suggests that, although those with amnestic MCI do not yet
meet neuropathological criteria for AD, they are also not neuropathologically equivalent
to their cognitively normal peers.
Non-amnestic MCI
Non-Amnestic MCI consists of a primary deficit in a cognitive domain other than
memory, such as language, executive functioning, or visuospatial functioning. The
prevalence of non-amnestic MCI, including both single and multiple domains, has been
found to range from 9% to 15% in a sample of adults age 75 and older (Busse et al.,
2006; Jungwirth, Weissgram, Zehetmayer, Tragl, & Fischer, 2005) and to occur in 17%
of an ethnically diverse sample aged 65 and older (Manly et al., 2005). The non-amnestic
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subtype of MCI has been found to be either more prevalent than or equally as prevalent
as amnestic MCI (Busse et al., 2006). Furthermore, multiple domain non-amnestic MCI,
which was found in 2% of a sample of older adults, is much less common than the single
domain non-amnestic version, which was found in 7% of the same sample (Busse et al.,
2006).
According to Busse and colleagues (2006), 34% of their sample of single domain
non-amnestic MCI patients and 21% of their multiple domain patients converted to some
form of dementia by the end of a four-year follow-up period. Similar to other studies in
this area (e.g., Fischer et al., 2007), this rate of conversion was lower than that found for
patients with amnestic MCI. Of the non-amnestic patients that did convert, 60% of the
single domain non-amnestic patients and 50% of the multiple domain patients converted
to AD. The remainder of the single domain non-amnestic sample converted either to
vascular dementia (VD) (15%) or another form of dementia (25%). The remaining 50%
of the multiple domain non-amnestic sample converted to another form of dementia,
other than AD or VD. Interestingly, AD was the most common form of dementia which
patients converted to, except for those with multiple domain non-amnestic MCI. In this
case, these patients were just as likely to convert to a different form of dementia as they
were to AD (Busse et al., 2006).
These results support the hypothesis that, in the same way that amnestic MCI may
be a prodromal form of AD, non-amnestic forms of MCI may be prodromal periods for
other dementias, such as VD or frontotemporal dementia (FTD) (Busse et al., 2006; Yaffe
et al., 2006). However, this hypothesis is still controversial and has not been
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unequivocally supported (e.g., Fischer, 2007; Loewenstein, 2006). For instance, in a
study examining those with MCI who converted to AD or VD, there were no differences
found in the memory, language, visuospatial, or executive functioning of the two groups
(Loewenstein, 2006). In other words, no neuropsychological criteria could differentiate
those who later converted to AD or VD.
Although those with amnestic MCI may exhibit slight deficits in executive
functioning (e.g., Rabin, 2006), executive function deficits are of particular interest in
those with non-amnestic MCI (Petersen, 2004; Winblad et al., 2004). Executive functions
(EFs) refer to a diverse set of higher order functions typically localized in prefrontal brain
regions (Denckla, 1996). EFs have historically been thought to include planning,
decision-making, judgment, and self-regulation, although the precise nature of EFs is still
under debate (Han, 2008). More specifically, EFs are thought to be manifested in the
ability to inhibit an unwanted response, such that one is able to consider all alternative
solutions to a problem instead of impulsively acting (Han, 2008). Once a suitable
decision is settled upon, EFs allow one to initiate and maintain behavior to reach a goal
or solve a problem (Han, 2008). Furthermore, EFs involve the ability to generate and
maintain a set of “rules” pertaining to one’s current activity in order to successfully
complete a task, as well as the ability to flexibly switch between cognitive sets in
response to changes in one’s goals or the demands of the environment (Han, 2008).
Finally, EFs allow one to plan and organize behaviors in order to better reach goals and
also to monitor oneself to determine whether proper goal-oriented behaviors are being
performed (Han, 2008).
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Patients with a dysexecutive form of non-amnestic MCI will exhibit impairments
in executive functions. Executive impairments can have a varied presentation, reflecting
the diverse nature of executive functions. In general, executive functioning impairments
may include difficulties monitoring oneself, difficulties focusing attention or switching
attentional focus, and difficulties in decision making.
Neuroimaging in MCI Subtypes
Amnestic MCI
Because those with amnestic MCI exhibit significant impairments in episodic
memory, the hippocampus, a brain structure integral to memory functioning, has been
frequently studied in these patients. This structure is shown below in Figure 1. Among
other things, the hippocampus is critical for the formation of episodic memories, or the
personal memories one forms throughout life (Mesulam, 2000). The hippocampus is
found in the limbic system in the temporal lobes of the brain and receives inputs from
brain regions associated with all sensory modalities as well as from other subcortical
regions (Mesulam, 2000).
Although older memories are typically accessed through other brain regions
beyond the hippocampus, the activity of the hippocampus is critical for new memories to
be learned and their connections with previously learned information strengthened
(Mesulam, 2000). Evidence from patients with amnesia has also suggested the
importance of the hippocampus for the retrieval of previously stored memories
(Mesulam, 2000). When hippocampal volume is lost, new information is not encoded as
effectively nor are memories retrieved as easily (Mesulam, 2000). These findings may
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help explain the difficulties patients with amnestic MCI have in learning new information
and remembering recent life events.

Figure 1. Coronal, saggital, and axial views of the hippocampus (Collins, Zijdenbos, &
Evans, 1998).
Magnetic Resonance Imaging (MRI) research has supported the connection
between amnestic MCI and hippocampal atrophy (see Pihlajamaki et al., 2009 and Ries et
al., 2008, for reviews). Several studies have indicated that patients with amnestic MCI
display smaller hippocampal volumes than cognitively normal controls (e.g., Bai et al.,
2009; Becker et al., 2006; Bell-McGinty et al., 2005; Schmidt-Wilcke, Poljansk,
Hierlmeier, Hausner, & Ibach, 2009; Shi, Liu, Zhou, Yu, & Jiang, 2009; Stoub et al.,
2006; Whitwell et al., 2007). In a meta-analytic review of 14 studies comparing
hippocampal atrophy in patients with MCI, AD, and cognitively normal controls, MCI
patients were found to exhibit significant hippocampal atrophy in both hemispheres as
compared to controls (Shi et al., 2009). In fact, volumetric reductions between MCI
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patients and controls averaged 12.9% for left hippocampi and 11.1% for right hippocampi
(Shi et al., 2009). In comparison, patients with AD exhibited hippocampal volume
reductions compared to controls of 24.2% and 23.1% for left and right hippocampi,
respectively (Shi et al., 2009).
Becker and colleagues (2006) compared manually traced hippocampal volumes
obtained through three-dimensional structural MRI in those with AD, amnestic MCI, and
cognitively normal controls. Patients with both AD and amnestic MCI were found to
have smaller hippocampi than controls. Moreover, the hippocampal volumes of those
with AD and amnestic MCI did not differ. In a similar study by Stoub and associates
(2006), hippocampal volumes of patients with amnestic MCI and cognitively normal
controls were obtained using both whole brain, voxel-based morphometry and manual
tracing of the hippocampus in structural MRI images. MCI patients exhibited
significantly more hippocampal atrophy than controls; in addition, hippocampal atrophy
was associated with decreased memory performance (Stoub et al., 2006). Bell-McGinty
et al. (2005) also compared volumes of several brain regions, including the hippocampus,
among two subtypes of MCI and cognitively normal controls using voxel-based
morphometry. As expected, those with amnestic MCI had significantly smaller
hippocampi than controls (Bell-McGinty et al., 2005). Whitwell and colleagues (2007)
also used voxel-based morphometry to compare the four subtypes of MCI with
cognitively normal controls; those with the amnestic variant, both single and multiple
domains, were found to have smaller hippocampal volumes than controls.
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Because hippocampal atrophy is a continuous, degenerative process, it is critical
to consider the association between hippocampal volume and diagnosis over time. Jack
and colleagues (2004) reported the results of a longitudinal study of the relationship
between manually traced hippocampal volumes and conversion to MCI and AD using
structural MRI. The authors found that hippocampal volumes were smaller in cognitively
normal adults who later converted to MCI than in those whose diagnosis remained stable,
a finding also reported in other studies (e.g., Martin, Smith, Collins, Schmitt, & Gold,
2010). Similarly, Jack et al. (2004) found that the hippocampi of patients with MCI who
later converted to AD were smaller than that of MCI patients’ who did not convert to AD.
In addition, hippocampal atrophy was commonly visible when no significant
neuropsychological or functional deficits were apparent (Jack et al., 2004). Wang, Liu,
Lirng, Lin, & Wu (2009) also investigated the association of hippocampal atrophy and
diagnosis over time. Their findings, similar to those of Jack et al. (2004), indicated that
patients with amnestic MCI who later converted to AD had the highest hippocampal
atrophy rates compared to both controls and MCI patients who remained stable.
Furthermore, MCI patients whose diagnosis remained stable exhibited a rate of
hippocampal atrophy intermediate of that found in controls and progressive MCI patients
(Wang et al., 2009).
In a similar study using voxel-based morphometry (Karas et al., 2008), amnestic
MCI patients who had converted to AD by a three-year follow-up had smaller
hippocampi than MCI patients who remained stable. After controlling for demographic
variables, total brain volume, and time of neuropsychological assessment, this difference
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was only significant for the left hippocampus (Karas et al., 2008). Devanand and
colleagues (2007) also compared hippocampal volumes among controls, MCI patients
who later converted to AD, and MCI patients whose diagnosis remained stable. The
authors found that hippocampal volumes of stable MCI patients were intermediate
between controls and MCI patients who later converted to AD. As expected, MCI
patients who converted to AD exhibited the smallest hippocampal volumes of all the
groups studied (Devanand et al., 2007).
Measurement of hippocampal atrophy has also been suggested for use in the
diagnosis of amnestic MCI. One study examined the diagnostic utility of manually traced
hippocampal volumes in comparison to and in addition to the Mini Mental Status Exam
(MMSE) for amnestic MCI patients (Slavin, Sandstrom, Tran, Doraiswamy, & Petrella,
2007). The left hippocampus was found to be more accurate in diagnosing amnestic MCI
than the right hemisphere, although there were no differences between the efficacy of
diagnosis with hippocampal volumes and use of the MMSE. Importantly, however, the
diagnostic efficacy produced by addition of the left hippocampal volumes to MMSE
scores was significantly greater than that from the MMSE alone (Slavin et al., 2007).
However, in a study by Fleisher and associates (2008), hippocampal atrophy was found
to predict conversion of amnestic MCI to AD with only 60% accuracy. In contrast,
prediction using neuropsychological measures fared much better, with nearly 79%
predictive accuracy (Fleisher et al., 2008). Thus, although hippocampal atrophy may be
able to be used in a diagnostic capacity, this practice is still under scrutiny (Slavin et al.,
2007).
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Amnestic and Non-amnestic MCI Compared
Due to the recent development of the non-amnestic MCI subgroup, all
neuroimaging studies involving non-amnestic MCI patients have compared them with
amnestic MCI patients. Patients with non-amnestic
MCI have typically been found to exhibit atrophy in the frontal cortex as compared with
controls and amnestic MCI patients. Pa et al. (2008) used voxel-based morphometry to
compare amnestic and non-amnestic MCI patients and cognitively normal controls.
Those with amnestic MCI were found to have smaller hippocampal volumes than
controls, while non-amnestic MCI patients were found to have smaller volumes in
dorsolateral and dorsomedial prefrontal cortices than controls. However, when the two
MCI subtypes were compared with one another, these differences were not maintained
(Pa et al., 2008).
The findings of functional studies have generally echoed those using structural
imaging. A study using SPECT reported that amnestic MCI patients exhibited reduced
metabolism in the hippocampus when compared to controls; in contrast, those with nonamnestic MCI had reduced metabolism in the right frontal cortex (Nobili et al., 2008).
Machulda and colleagues (2009) asked amnestic and non-amnestic patients to perform
encoding and recognition memory tasks which required them to remember a complex
scene while undergoing functional Magnetic Resonance Imaging (fMRI). During the
recognition portion of the task, non-amnestic MCI patients were found to exhibit less
activity in frontal brain regions than cognitively normal controls (Machulda et al., 2009).

32
Although the effect of MCI diagnosis on atrophy in several different brain regions
has been examined, the anterior cingulate cortex is of particular interest in relation to
executive functioning. The anterior cingulate cortex (ACC) is located in the medial
frontal region of the brain and receives most of its subcortical connections from the
amygdala (Mesulam, 2000). This structure is shown below in Figure 2 and includes the
pink, blue, and yellow areas. The anterior cingulate cortex is involved in several
executive functions, including emotional regulation, general attention and engagement
with the environment (Mesulam, 2000), as well as the prevention of errors through
detecting incompatibilities between one’s behavior and other response tendencies (Carter,
2000). In fact, Rosen and colleagues (2005) demonstrated that ACC atrophy is associated
with several deficits in executive functions, including apathy and disinhibition.

Figure 2. Saggital view of the brain illustrating ACC divisions. Rostral ACC is shown in
pink, dorsal ACC in blue, and subcallosal ACC in yellow (Koo et al., 2008).
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The ACC can be divided into rostral, dorsal, and subcallosal regions. The rostral
ACC, colored pink in Figure 2, receives most of its input from limbic and paralimbic
regions such as the nucleus accumbens, amygdala, insula, hippocampus, and orbitofrontal
cortex, many of which are involved in affective regulation. As such, the rostral ACC is
associated with assessing the relevance of emotional and motivational cues in the
environment in order to regulate emotional responses (Bush, 2000). The dorsal ACC,
which is blue in Figure 2, is interconnected with several cortical areas, including the
lateral prefrontal cortex, parietal cortex, and premotor and supplementary motor areas
(Koo et al., 2008). This region is involved in attention, executive functions, detection of
errors, and memory (Koo et al., 2008). The subcallosal region, colored yellow in Figure
2, is highly connected with subcortical regions associated with mood (Koo et al., 2008).
In one study using voxel-based morphometry with MCI patients and cognitively
normal controls, a section of the left anterior cingulate gyrus was found to be smaller in
those with MCI than controls (Pennanen et al., 2005). In addition, MCI patients also
exhibited atrophy in the medial temporal lobe, which includes the hippocampus, in the
right hemisphere. Unfortunately, however, the authors did not discriminate between
different subtypes of MCI. It is therefore unclear from the results of this study alone
whether ACC atrophy is associated with MCI patients in general or non-amnestic MCI
patients in particular.
More recent studies in this area, which differentiate between subtypes of MCI,
allow more definitive interpretations of results to be drawn. Caffarra and colleagues
(2008) reported results from a study of regional cerebral blood flow measured with
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SPECT. Although blood flow does not directly indicate regional volume, smaller
volumes can be inferred from lower blood flow in the region (e.g., Schaller, 2008). The
authors compared those with amnestic MCI to those with dysexecutive, non-amnestic
MCI (i.e., those with executive functioning deficits). Whereas amnestic MCI patients had
lower levels of blood flow than controls in the hippocampus, dysexecutive MCI patients
had lower levels of blood flow in the anterior cingulate cortex (Caffarra et al., 2008). In
addition, Johnson, Vogt, Kim, Cotman, & Head (2004) reported the results of an autopsy
performed with a patient who exhibited primary executive functioning deficits, as
assessed by the Trail Making Test parts A and B. The autopsy revealed neuropathies,
including NFTs and amyloid plaques, dispersed throughout the brain. However, the
density of Aβ42, the primary component of amyloid plaques, was greatest in the ACC,
particularly around the genu of the corpus callosum (Johnson et al., 2004).
Finally, Jauhiainen et al. (2008) performed structural MRI and Positron Emission
Tomography (PET) with a sample of patients with amnestic MCI, non-amnestic MCI,
and cognitively normal controls. While the amnestic MCI patients did not differ from
controls in the volumes of any brain regions, non-amnestic patients had smaller volumes
in several frontal areas, including the anterior cingulate cortex, than controls.
Furthermore, non-amnestic patients had smaller volumes in several frontal regions than
amnestic MCI patients (Jauhiainen et al., 2008). In contrast, results with the PET scans
indicated that amnestic patients exhibited hypometabolism in medial temporal lobe areas
including the hippocampus as compared to both controls and non-amnestic MCI patients.
However, no differences in the metabolism in frontal lobe regions were found between
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the non-amnestic patients and either amnestic patients or controls (Jauhiainen et al.,
2008).
Current Study
Description and Purpose
Research on patients with MCI has grown in frequency due in part to the
possibility of preventing the development of MCI and various forms of
dementia, particularly AD, in the future. Although those with amnestic MCI and nonamnestic MCI differ in numerous respects, research comparing these two subtypes is only
in its nascent stages. Particularly because different types of dementia have distinct
patterns of brain atrophy, it is important to research structural imaging correlates in
subtypes of MCI. Not only will this enhance the current knowledge regarding differences
between amnestic and non-amnestic MCI populations, but such research will also begin
to elucidate the etiology underlying the subtypes of MCI.
In accordance with these goals, this study examined the structural imaging
correlates of amnestic and non-amnestic MCI as compared to cognitively normal
controls. Using a manual tracing procedure, hippocampal and rostral, dorsal, and
subcallosal anterior cingulate cortex volumes were delineated. Hippocampal and whole
ACC volumes as well as rostral and dorsal ACC volumes were compared among all three
diagnostic groups. Subcallosal ACC volumes were not individually analyzed due to the
subregion’s limited relevance for executive functioning. Although a small number of
studies have reported findings with the anterior cingulate in MCI patients, no study to
date has specifically examined manually traced ACC volumes in both amnestic and non-
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amnestic populations, despite the relevance of the ACC to non-amnestic patients,
particularly those with executive dysfunction.
Hypotheses
This study examined hippocampal and ACC regional volumes among amnestic
MCI, non-amnestic MCI, and cognitively normal patients.
Hypothesis: There will be a significant interaction between brain region and
diagnostic group, indicating that the brain region volumes differ depending on
diagnosis. Specifically, it is predicted that amnestic MCI patients will have
smaller hippocampi than controls and non-amnestic patients, while having larger
ACC volumes than non-amnestic MCI patients. It is also predicted that nonamnestic MCI patients will have smaller ACC volumes than amnestic MCI
patients and controls, while having larger hippocampi than amnestic MCI
patients.
Post-hoc Hypotheses (to be investigated if brain region x diagnosis interaction is
significant):
Post hoc Hypothesis 1: Patients with amnestic MCI will have smaller hippocampi
than cognitively normal controls.
Post-hoc Hypothesis 2: Patients with amnestic MCI will have smaller hippocampi
than those with non-amnestic MCI.
Post-hoc Hypothesis 3: Patients with non-amnestic MCI will have smaller whole
anterior cingulate cortex volumes, as well as smaller volumes in dorsal and rostral
subregions, than cognitively normal controls.

37
Post-hoc Hypothesis 4: Patients with non-amnestic MCI will have smaller whole
anterior cingulate cortex volumes, as well as smaller volumes in dorsal and rostral
subregions, than those with amnestic MCI.

CHAPTER THREE
METHODS

Participants
Fifty-seven right-handed participants, including 21 cognitively normal controls,
20 with amnestic MCI, and 16 with non-amnestic MCI, were drawn from a sample of
community dwelling older adults recruited at the University of California San Diego
(UCSD) for a longitudinal study investigating normal aging. The sample was composed
of 44% men (n = 25) and 56% women (n = 32). Within each diagnostic group, the control
sample was composed of 33% men (n = 7) and 67% women (n = 14). The sample with
amnestic MCI was 50% men (n = 10) and 50% women (n = 10). The sample with nonamnestic MCI was also 50% men (n = 8) and 50% women (n = 8). Ninety-five percent of
the sample was white (n = 54) and 1.8% of the sample was Asian-American (n = 1).
Ethnicity data was not available for two participants. The overall sample had an average
age of 76.12 (SD = 7.26), an average educational level of 16.04 (SD = 2.25), an average
estimated verbal IQ (from the ANART) of 119.89 (SD = 6.16), and an average dementia
rating of 52.89 (SD = 5.79). These demographic factors, broken down by diagnostic
group, are shown below in Table 1.
Participants were drawn from a sample of community dwelling older adults
recruited at the University of California San Diego (UCSD) for a longitudinal study
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investigating normal aging. The participants for this study were selected by UCSD
researchers on the basis of their having received an MRI and a comprehensive
neuropsychological assessment prior to recruitment. Furthermore, only non-demented
participants were included in this study’s sample. UCSD researchers assessed the
presence of dementia by examining participants’ level of functional impairment using the
Independent Living Scales (ILS; Loeb, 1996) as well as participants’ level of global
cognitive functioning using the Dementia Rating Scale (DRS; Mattis, 1988). Only those
participants with normal global cognitive functioning and without functional impairment
were included in the sample. Additional exclusion criteria included history of
neurological or severe psychiatric illness, learning disability, or a history of drug or
alcohol abuse. All participants gave written informed consent prior to participation in the
study.

Table 1. Mean Values for Demographic Variables by Diagnostic Group

Age

Education

DRS

ANART1

Controls

76.22 (5.55)

15.94 (2.24)

56.56 (3.24)

122.89 (4.10)

Amnestic MCI

74.15 (7.40)

16.30 (2.43)

49.60 (6.37)

117.70 (6.41)

Non-amnestic MCI

78.44 (8.16)

15.56 (2.22)

52.07 (4.79)

118.36 (6.81)

Diagnostic Group

Note. Standard deviations are in parentheses. 1ANART used as an estimate of verbal IQ.
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Demographics
Participant demographics were collected by a UCSD researcher prior to
participation. Such demographics included the participant’s age, education, and gender.
UCSD researchers ascertained participants’ general cognitive functioning through the
American National Adult Reading Test (ANART). The ANART requires participants to
read a list of 45 irregularly spelled words. Because the words are relatively short and
have irregular spelling (e.g., bouquet, depot), the test does not require participants to
process complex visual stimuli and does not allow the use of phonetics to deduce the
pronunciation of the words (Strauss, Sherman, & Spreen, 2006). As a result, a person’s
performance on the ANART is thought to reflect past knowledge (i.e., familiarity with
each irregularly spelled word) instead of current cognitive functioning (Strauss et al.,
2006). Thus, participants’ scores on the ANART were used as a proxy for full-scale IQ.
Finally, participants’ scores on the Dementia Rating Scale (DRS) were used to determine
their dementia stage. The DRS assesses five cognitive areas which are most likely to
show decline in early Alzheimer’s disease: attention, initiation and perseveration,
construction, conceptual abilities, and memory. As described in the results section, all
participant groups were compared on each of the above demographic variables to
determine equivalency. Any variable which significantly differed by diagnostic group
was controlled for in all subsequent analyses.
Neuropsychological Assessment
All participants were given a comprehensive neuropsychological evaluation by a
UCSD researcher prior to recruitment for the larger, longitudinal study from which this
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study’s participants were selected. This study focused only on those neuropsychological
tests assessing five relevant cognitive domains, including memory, executive functioning,
language, attention, and visuospatial function. Each of these domains is represented by at
least three neuropsychological tests within the larger battery. These tests were selected
for use in diagnosis in this study based on their common use with older adult populations
and their psychometric properties.
Memory Assessments
Three measures were used by UCSD researchers to assess participants’ memory.
Selected tests include the immediate and delayed recall portions from the Logical
Memory subtest of the Wechsler Memory Scale – Revised
(WMS-R; Wechsler, 1987) and the Visual Reproduction subtest of the WMS-R, as well as
Trials 1-5 total recall and long delay free recall from the California Verbal Learning Test
(CVLT; Delis et al., 1987).
Executive Functioning Assessments
Four tests were used by UCSD researchers to assess participants’ executive
functioning. Selected tests include the modified, 48-card version of the Wisconsin Card
Sorting Test (WCST; Lineweaver, Bondi, Thomas, & Salmon, 1999) specifically focusing
on categories achieved and perseverative errors, the Trail Making Test, Part B (Reitan &
Wolfson, 1985a), the inhibition and inhibition/switching conditions of the Delis-Kaplan
Executive Function Scale (D-KEFS; Delis, Kaplan, & Kramer, 2001a) Color-Word
Interference Test, and the switching condition of the design and verbal fluency tasks of
the D-KEFS.
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Language Assessments
Three tests were used by UCSD researchers to assess participants’ language
abilities. The selected tests include the Boston Naming Test (Kaplan, Goodglass, &
Weintraub, 1983), letter fluency, and category fluency (Gladsjo et al., 1999).
Attention Assessments
Three measures were used by UCSD researchers to assess participants’ level of
attention. Selected tests include the attention subscale of the DRS (Mattis, 1988), the
Digit Span subtest of the WAIS-R (Wechsler, 1981), and the Trail Making Test, Part A
(Reitan & Wolfson, 1985a).
Visuospatial Assessments
Five measures were used by UCSD researchers to assess participants’
visuospatial functioning. Selected tests include the Block Design
subtest of the Wechsler Intelligence Scale for Children-Revised (WISC-R; Wechsler,
1974), the Visual Scanning condition of the D-KEFS Trail Making Test, the empty and
filled dot conditions of the D-KEFS Design Fluency Test, DRS construction (Mattis,
1988), and draw-a-clock.
MCI Diagnosis
A UCSD researcher assessed participants for the presence of MCI using a
comprehensive set of diagnostic criteria developed by Jak et al. (2009). The criteria allow
a diagnosis of either amnestic MCI, single domain, if only the memory domain is
impaired, amnestic MCI, multiple domain, if the memory domain plus additional
cognitive domains are impaired, non-amnestic MCI, single domain, if one non-memory
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domain is impaired, and non-amnestic MCI, multiple domain, if more than one nonmemory domains are impaired. In order for a domain to be classified as impaired, the
person must score at least 1 SD below age-adjusted norms on at least two assessments
within the domain (Jak et al., 2009). This differs from the criteria historically used to
diagnose MCI (Storandt et al., 2006), which required impairment of at least 1.5 SD below
age-adjusted norms on only one assessment per cognitive domain.
The comprehensive diagnostic criteria were selected based on results indicating
that such criteria provided the best balance between sensitivity and specificity in
detecting cases of MCI and stability of the diagnostic categories (Jak et al., 2009). Thus,
although historical or conservative criteria provide above average diagnostic stability, it
is likely such criteria have a high false negative rate, missing many cases of MCI (Jak et
al., 2009). Likewise, although more liberal criteria detect more cases of MCI, they also
likely have a higher false positive rate and therefore increased diagnostic instability (Jak
et al., 2009). The comprehensive criteria which were used in this study strike a balance
between detecting cases of MCI while preserving the stability of the diagnostic categories
(Jak et al., 2009).
Structural Magnetic Resonance Imaging Acquisition and Image Analysis
Participants were scanned by a UCSD researcher using either a 3.0 Tesla General
Electric (GE) Medical Systems EXCITE whole body imager or a 1.5-Tesla GE Signa
imager (General Electric Medical Systems, Milwaukee, WI, USA). The images were
stripped of all skull material and segment them into gray matter, white matter, and
cerebrospinal fluid compartments. Residual non-brain material was manually removed
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when necessary. Whole-brain volume was determined and used in normalizing the region
of interest volumes (Bigler & Tate, 2001).
Regions of Interest Manual Tracing Protocol
Volumes for the anterior cingulate and hippocampus were obtained bilaterally
through manual tracing in the coronal plane using Analysis of Functional NeuroImages
(AFNI) software. Prior to tracing, the images were realigned so as to be perpendicular to
the anterior-posterior commissure line. However, images were not transformed into
standard space coordinates. Interrater reliability for the delineation of the regions of
interest was required to exceed .85 using a separate set of images not analyzed in this
study. More specifically, Dr. Amy Jak, a researcher from UCSD who is reliable on
tracing the ACC regions, as well as the student researcher, independently traced the ACC
regions in five brains not included in this study. The whole ACC, rostral, and dorsal ACC
volumes delineated by the tracings were compared between Dr. Jak and the student using
intra-class correlation to determine whether an acceptable tracing reliability had been
reached. The interrater reliability between Dr. Jak and the student researcher for tracing
the whole ACC was .94, and the interrater reliabilities for tracing the left and right rostral
and dorsal ACCs ranged from .94 to .99. Once reliability was established, the student
researcher completed manual tracing of the ACC regions of interest for all participants
included in the study, while being blind to participant identity and group.
The procedure for tracing the anterior cingulate cortex was adapted from a
previously published methodology (Fornito et al., 2006). A more detailed manual
describing the boundaries and tracing procedures was obtained from the authors. This
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particular methodology was chosen due to the clarity with which it describes the
boundaries used in delineation, increasing the ease with which the boundaries can be
reliably reproduced. In addition, several other structural imaging studies have used this
methodology as well.
The anterior cingulate cortex, divided into rostral, dorsal, and subcallosal
portions, was traced bilaterally in the coronal plane. Although subcallosal volumes were
not individually analyzed, this region was still individually delineated in order to identify
the rostral and dorsal subregions of the ACC. Prior to tracing, three boundaries were
established for the regions of interest. The midline, identified in the saggital plane and
defined as the slice in which the septum pellucidum is most visible, was masked out to
prevent regions of interest from containing gray matter belonging to the other
hemisphere. The posterior boundary for the anterior cingulate cortex was identified in the
coronal plane and was defined as the first slice in which the anterior commissure no
longer crosses the midline of the brain. The boundary dividing the rostral and dorsal
portions of the anterior cingulate, termed Plane A, was also identified in the coronal plane
and was defined as the first slice in which the white matter of the corpus callosum can be
seen crossing the midline of the brain.
Before the regions of interest are delineated, the sulci of each brain were
examined according to the tracing methodology and an additional protocol (Fornito et al.,
2006; Yucel et al., 2001) to determine whether the brain contained a paracingulate sulcus.
The presence or absence of a paracingulate sulcus affects the way in which the regions of
interest are delineated. The paracingulate sulcus was deemed present if a sulcus is present
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dorsal to the cingulate sulcus and if parallel portions of the sulci overlap for at least 20
mm before reaching the posterior boundary of the anterior cingulate. Furthermore, this
overlap should continue for at least three slices laterally for the presence of the
paracingulate sulcus to be counted. The origin of the paracingulate sulcus was defined as
the point at which the sulcus arches away from a vertical line. Should two sulci overlap
for less than 20 mm, this was counted as a segmented cingulate sulcus. The tracing of
such a sulcus is described below. Although the Yucel et al. (2001) protocol requires that
the inferior sulcus originate anterior to the corpus callosum to be considered the cingulate
sulcus, following the recommendation of Fornito et al. (2006), any overlap of sulci
greater than 20 mm was counted as the presence of a paracingulate sulcus, regardless of
the origin of the inferior sulcus.
Should a paracingulate sulcus be present, the gray matter dorsal to the cingulate
sulcus was not included in the regions of interest and was instead counted as part of the
paracingulate cortex. Should the sulcal pattern represent a segmented cingulate sulcus
in which there is less than 20 mm of overlap, the area of overlap between the sulci were
included in the region of interest. In the case where two parallel sulci overlap for more
than 20 mm but there is an additional sulcus more dorsally, the area of overlap was
counted in the region of interest if it lies under the more dorsal sulcus. However, if the
area of overlap does not lie under the more dorsal sulcus, it was not included in the region
of interest and was counted as part of the paracingulate cortex.
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Once the presence or absence of a paracingulate sulcus was established, each
region of interest was traced bilaterally in the coronal plane. All regions of interest were
traced in one hemisphere and then the other. In general, boundaries for regions of
interest were traced in the center of the relevant sulcus. Boundaries for each region of
interest are given below.
The rostral anterior cingulate cortex was bordered posteriorly by Plane A. The
anterior, dorsal, and inferior boundaries were the cingulate sulcus. In cases where the
cingulate sulcus is continuous with another sulcus, such as the superior rostral sulcus, the
boundary was traced along the joined portion to the posterior boundary. If the cingulate
sulcus is separate from other sulci but does not reach to Plane A, a line following the
imagined path of the cingulate sulcus was traced back to Plane A. The dorsal anterior
cingulate was bounded dorsally by the cingulate sulcus and posteriorly by the posterior
border. The anterior boundary was Plane A, while the inferior boundary was the corpus
callosum. The subcallosal anterior cingulate was bounded dorsally by the corpus
callosum, anteriorly by Plane A, and inferiorly by the cingulate sulcus. The posterior
boundary was the first slice in which the internal capsule clearly separates the caudate
and putamen.
Examples of tracings of the ACC done for this study are shown below in Figures
3, 4, and 5. Figure 3 depicts the tracing of the ACC of a cognitively normal control
participant, Figure 4 depicts the tracing of the ACC of a patient with amnestic MCI, and
Figure 5 depicts the tracing of the ACC of a patient with non-amnestic MCI. In all
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Figures, the rostral ACC is in green, the dorsal ACC is in yellow, and the subcallosal
ACC is in orange.

Figure 3. Tracing of the ACC of a cognitively normal control participant completed for
the current study. Rostral ACC is in green, dorsal ACC is in yellow, and subcallosal ACC
is in orange.

Figure 4. Tracing of the ACC of a patient with amnestic MCI completed for the current
study. Rostral ACC is in green, dorsal ACC is in yellow, and subcallosal ACC is in
orange.
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Figure 5. Tracing of the ACC of a patient with non-amnestic MCI completed for the
current study. Rostral ACC is in green, dorsal ACC is in yellow, and subcallosal ACC is
in orange.
Hippocampal regions of interest were traced by UCSD researchers according to a
previously published protocol (Jak et al., 2007). The anterior boundary was the slice
through the fullest part of the mammillary bodies, while the posterior boundary was the
last slice in which the superior colliculi are still fully visible.
Procedure
Prior to participation, participants provided written informed consent for a larger,
ongoing longitudinal study at UCSD. Participants were then screened for dementia by
UCSD researchers using the ILS and DRS scales. Only those participants who were free
of functional impairment and who displayed normal cognitive functioning were included.
UCSD researchers then gave participants a comprehensive neuropsychological battery,
which was used to determine whether a diagnosis of MCI would be appropriate.
Participants were deemed cognitively normal or diagnosed with either amnestic MCI or
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non-amnestic MCI, according to the diagnostic criteria outlined above. Finally,
participants also underwent a structural MRI at UCSD.
Data Analysis
Participants in each group, cognitively normal controls, those with amnestic MCI,
and those with non-amnestic MCI, were compared on all relevant demographic variables,
including age, education, gender, IQ, as measured by the ANART, and dementia stage, as
measured by the DRS. Four between-subjects analyses of variance (ANOVAs) were used
to compare the groups on age, education, IQ, and dementia stage. When significant
differences were found, these variables were controlled for in subsequent analyses. Chisquare analyses were also performed to determine the existence of group differences on
gender.
Prior to analysis, all ROI volumes were converted to percentages for each
participant. This was done by dividing the ROI volume by the participant’s whole brain
volume and multiplying by 100. In this way, differences in whole brain volume, which
may vary between participants, was controlled for. Brain volumes were analyzed using
two mixed-model analyses of variance (ANOVA). The first ANOVA consisted of the
between-subjects variable Diagnosis (amnestic MCI, non-amnestic MCI, cognitively
normal) and within-subjects variable Region of Interest (left and right hippocampus, left
and right whole ACC) The second ANOVA consisted of the between subjects variable
Diagnosis (amnestic MCI, non-amnestic MCI, cognitively normal) and within subjects
variable Region of Interest (left and right hippocampus, left and right dorsal ACC, left
and right rostral ACC). Of particular interest in this study was whether a significant
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interaction between diagnosis and brain region was found, indicating that brain region
volumes differ depending on diagnosis.

CHAPTER FOUR
RESULTS

The diagnostic groups were compared on age, education, Dementia Rating Scale
(DRS) score, and estimated verbal IQ using one-way analysis of variance (ANOVA).
Groups were compared on gender using Pearson’s chi-square analysis. The groups were
not found to differ in terms of gender, χ2(2, N = 57) = 1.50, p = .47. There were no
significant differences among the diagnostic groups in terms of age, F(2, 51) = 1.63, p =
.21. Similarly, the diagnostic groups did not differ in terms of education, F(2, 51) = 0.46,
p = .64. The diagnostic groups were found to differ significantly on estimated verbal IQ,
F(2, 51) = 4.23, p = .02, and DRS score, F(2, 51) = 9.17, p < .001. Because the diagnostic
groups differed on estimated verbal IQ and DRS score, these variables were used as
covariates in subsequent mixed-model ANOVAs.
Hippocampal and ACC volumes were compared across the three diagnostic
groups (cognitively normal, amnestic MCI, non-amnestic MCI) using two mixed-model
analyses of variance. In the first model, the within-subjects variable was Region of
Interest (left and right hippocampal volumes and left and right whole ACC volumes),
while the between-subjects variable was Diagnosis (cognitively normal, amnestic MCI,
non-amnestic MCI). In the second model, the within-subjects variable was Region of
Interest (left and right hippocampal volumes and left and right rostral and dorsal ACC
52
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volumes), while the between subjects variable was Diagnosis (cognitively normal,
amnestic MCI, non-amnestic MCI). Mean ROI volumes for each diagnostic group are
presented in Figure 6.
The first mixed-model ANOVA included ROI (left and right hippocampal
volumes and left and right whole ACC volumes) as the within-subjects variable and
Diagnosis (cognitively normal, amnestic MCI, non-amnestic MCI) as the betweensubjects variable. It was hypothesized that the interaction between Region of Interest and
Diagnosis would be significant, indicating that brain region volume differed by
diagnostic group. This prediction was not supported; the interaction of Region of Interest
and Diagnosis was not significant, F(6, 156) = 0.68, p = .67. This implies that left and
right hippocampal and whole ACC volumes did not differ across diagnostic groups. The
interaction between estimated verbal IQ and ROI was also not significant, F(3, 156) =
2.15, p = .10, indicating that ROI volumes did not differ by estimated verbal IQ.
Furthermore, the interaction between ROI and DRS score was not significant, F(3, 156) =
1.42, p = .24, which suggests that ROI volumes did not vary with dementia severity.
In examining results of the main effects, it was found that the main effect of
Diagnosis was not significant, F(2, 52) = 1.20, p = .31. Thus, it appears that, across all
Regions of Interest, brain volumes did not differ by diagnostic group. The main effects of
estimated verbal IQ (F(1, 52) = 0.01, p = .91) and DRS score (F(1, 52) = .44, p = .51)
were also not significant, suggesting that ROI volume across diagnostic group did not
differ by estimated verbal IQ or dementia severity. Finally, the main effect of ROI was
also not significant, F(3, 156) = 1.01, p = .39, suggesting that hippocampal and whole

Figure 6. Mean Percentage of Whole Brain Volume for each Region of Interest by Diagnostic Group
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ACC brain region volumes did not significantly differ from one another. Because
significant results were not found, post-hoc analyses were not performed.
The second mixed-model ANOVA included Region of Interest (left and right
hippocampus and left and right rostral and dorsal ACC) as the within-subjects variable
and Diagnosis (cognitively normal, amnestic MCI, non-amnestic MCI) as the betweensubjects variable. It was hypothesized that the interaction between Region of Interest and
Diagnosis would be significant, indicating that region of interest volumes differed across
diagnostic groups. This hypothesis was not supported, as the interaction between Region
of Interest and Diagnosis was not significant, F(10, 260) = 1.00, p = .44. Thus, it appears
that left and right hippocampal and rostral and dorsal ACC volumes did not differ across
diagnostic groups. Furthermore, the interaction between ROI and estimated verbal IQ
was not significant, F(5, 260) = 1.88, p = .10, indicating that ROI volumes did not vary
according to estimated verbal IQ. The interaction between ROI and DRS score was also
not significant, F(5, 260) = 2.06, p = .07, which suggests that ROI volumes did not differ
by dementia severity.
In terms of main effects, the main effect for Diagnosis was not significant, F(2,
52) = 1.21, p = .31. Thus, it appears that, across all ROIs, brain volumes did not differ
based on a person’s diagnostic category. The main effect of estimated verbal IQ was also
not significant, F(1, 52) = 0.001, p = .98, suggesting that ROI volume did not differ by
estimated verbal IQ. Finally, the main effect of DRS score was not significant, F(1, 52) =
.66, p = .42, which indicates that ROI volume was not associated with dementia rating.
Because no significant results were found, post-hoc analyses were not performed.

CHAPTER FIVE
DISCUSSION

The purpose of the current study was to determine whether hippocampal and
Anterior Cingulate Cortex volumes differed across patients with amnestic MCI, nonamnestic MCI, and cognitively normal controls. Much research has examined
hippocampal volumes in MCI subtypes, particularly the amnestic variant (see
Pihlajamaki et al., 2009; Ries et al., 2008; and Shi et al., 2009, for reviews). As expected,
their findings indicate that amnestic MCI is associated with hippocampal atrophy when
compared with cognitively normal controls (e.g., Bai et al., 2009; Becker et al., 2006;
Bell-McGinty et al., 2005; Schmidt-Wilcke et al., 2009; Shi, et al. 2009; Stoub et al.,
2006; Whitwell et al., 2007). Such atrophy is strongly related to their concomitant
memory deficits and is consistent with the more severe hippocampal tissue loss
characteristic of AD (e.g., Shi et al., 2009).
However, because the non-amnestic MCI variant was only recently created by the
International Working Group on Mild Cognitive Impairment in 2004 (Winblad et al.,
2004), research on the neuroimaging correlates of this subtype is lacking. What research
has been done suggests that patients with non-amnestic MCI exhibit atrophy in frontal
regions associated with executive functions, such as the dorsolateral and dorsomedial
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prefrontal cortices (Pa et al., 2008). Functional imaging studies have also found evidence
of frontal involvement in patients with non-amnestic MCI. A study using SPECT (Nobili
et al., 2008) reported lower levels of blood flow in non-amnestic MCI patients in the right
frontal cortex, while a study using fMRI (Machulda et al., 2009) found less activity in
frontal regions in non-amnestic MCI patients when performing a memory task.
Despite its involvement in executive functioning, the ACC has rarely been
included in such research. The ACC, composed of rostral, dorsal, and subcallosal
subregions, is thought to be involved in emotion regulation, attention, and error detection,
all skills necessary for optimal executive functioning (Carter, 2000; Koo et al., 2008;
Mesulam, 2000). What research has examined the ACC in relation to non-amnestic MCI
has found that non-amnestic MCI patients, particularly those with EF deficits, may
exhibit lower levels of blood flow in the ACC (Caffarra et al., 2008), smaller ACC
volumes (Jauhiainen et al., 2008), and a concentration of neuropathologies in the ACC
upon autopsy (Johnson et al., 2004). Yet, the ACC has not been examined in these
populations using manual tracing procedures, which many consider to be more accurate
delineations of an ROI than automated methods (Tisserand et al., 2002). Nor have ACC
volumes been examined in relation to hippocampal volumes in both amnestic and nonamnestic MCI variants. This study aimed to address these oversights in the literature by
comparing manually traced hippocampal and ACC volumes across patients with amnestic
MCI, non-amnestic MCI, and cognitively normal controls.
It was hypothesized that patients with amnestic MCI would have smaller
hippocampi when compared to both cognitively normal controls and those with non-
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amnestic MCI, while patients with non-amnestic MCI were hypothesized to have smaller
ACCs than cognitively normal controls and amnestic MCI patients. To test these
hypotheses, two mixed-model analyses of variance (ANOVAs) were conducted. The first
mixed-model ANOVA included ROI (left and right hippocampal volumes and left and
right whole ACC volumes) as the within-subjects variable and Diagnosis (cognitively
normal, amnestic MCI, non-amnestic MCI) as the between-subjects variable. The second
mixed-model ANOVA included Region of Interest (left and right hippocampus and left
and right rostral and dorsal ACC) as the within-subjects variable and Diagnosis
(cognitively normal, amnestic MCI, non-amnestic MCI) as the between-subjects variable.
In both of these analyses, of particular interest was the Region of Interest x
Diagnosis interaction, which would indicate that the ROI volumes differed according to
diagnosis. Contrary to predictions, this interaction was not significant in either analysis,
preventing follow-up post-hoc tests from being conducted to assess the study’s specific
hypotheses. This lack of significance implies that left and right hippocampal and left and
right whole, rostral, and dorsal ACC volumes did not vary by a patient’s diagnosis.
Some studies have also failed to find significant differences in hippocampal and
ACC volumes between MCI patients and controls. One study examining amnestic MCI
patients whose diagnosis remained stable and patients who later converted to AD found
no hippocampal volume differences from controls for those patients who remained stable
(Whitwell et al., 2008). A second study examined hippocampal volumes in cognitively
normal controls and in patients with amnestic MCI or AD (Hua et al., 2008). While
patients with AD exhibited significant levels of hippocampal atrophy compared to
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controls, patients with MCI showed no differences in hippocampal volume (Hua et al.,
2008).
Some studies assessing ACC involvement across diagnostic groups have also
failed to find significant results. Importantly, most of these studies examined functional
instead of structural differences in the ACC and most did not differentiate between
subtypes of MCI. An fMRI study of patients with MCI found no differences between
patients and controls in ACC activation during an attentional control task (Rosano et al.,
2005). A study examining regional cerebral blood flow in MCI and AD patients found no
significant differences in blood flow in the ACC between MCI patients and controls, and
AD patients actually had increased regional blood flow in the ACC compared to controls
(Dai, Lopez, Carmichael, Becker, Kuller, & Gach, 2009). The authors conceptualized this
finding as evidence for a compensatory response in the ACC in patients with cognitive
decline (Dai et al., 2009). This was also suggested by two studies examining
neuropathologies in the brains of patients who met post-mortem criteria for AD but were
asymptomatic (Iacono et al., 2008; Ruidavets et al., 2007). The authors found
hypertrophy in the ACC in these patients compared with control and MCI patients and
suggested that this may act to offset cognitive decline (Iacono et al., 2008; Ruidavets et
al., 2007). Also in support of a compensatory response in the ACC, an additional study
examining MCI patients over time using SPECT found that those who converted to AD
had higher levels of perfusion in the rostral anterior cingulate than non-converters and
controls (Johnson, Moran, Becker, Blacker, Fischman, & Albert, 2007). In contrast, no
differences were found between controls and non-converters in ACC perfusion. This
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study also found converters to have lower levels of perfusion in caudal regions of the
anterior cingulate and posterior cingulate (Johnson et al., 2007).
Following from these results, it may be that ACC pathology found in MCI and
AD is limited to caudal ACC regions, with rostral regions of the ACC showing a
compensatory response. Another explanation may be that ACC pathology begins
caudally, closer to the posterior cingulate, and moves anteriorly, while the rostral ACC
initially shows a compensatory response. Indeed, many studies have reported posterior
cingulate involvement early on in the AD disease course (e.g., Twamley, Ropacki, &
Bondi, 2006). Importantly, ACC boundaries vary across studies which examine it. It is
possible that conflicting results regarding the involvement of the ACC in MCI may be
due to the use of different boundaries to delineate the ACC. However, in comparing the
delineation methods of studies that found ACC atrophy in MCI subtypes (e.g., Caffarra et
al., 2008; Jauhiainen et al., 2008) with those that did not (e.g., Dai et al., 2009; Rosano et
al., 2005), no clear pattern emerges. Studies reporting ACC atrophy in MCI and those
finding no atrophy both utilized similar delineation methods; all used either automated
delineation or histological methods. However, it may be that the boundaries in the current
study excluded posterior portions of the ACC, which Johnson et al. (2007) found to be
affected in MCI patients who convert to AD, causing significant group differences in
posterior ACC regions to be missed.
Yet, the current study’s findings contrast with several studies that have reported
smaller hippocampal volumes among amnestic MCI patients than cognitively normal
controls (e.g., Bai et al., 2009; Becker et al., 2006; Bell-McGinty et al., 2005; Schmidt-
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Wilcke et al., 2009; Shi et al., 2009; Stoub et al., 2006; Whitwell et al., 2007).
Furthermore, although only a few studies have explored ACC volumes in MCI patients,
some of these studies reported significant differences between MCI patients and controls
(e.g., Jauhiainen et al., 2008; Pennanen et al., 2005).
The discrepancy between the findings of this study and those of other studies in
this area may be due to several factors. First, it may be that the ACC is not involved in
the degenerative processes associated with MCI. It is possible that the ACC only
becomes affected farther along in the course of dementia. This would suggest that ACC
differences might only be found in comparing different forms of dementia (e.g., AD vs.
FTD) or in comparing MCI patients whose deficits are fairly advanced. If this is indeed
the case, the exclusion of patients with dementia from the present study may have
prevented the detection of significant differences in brain region volumes. In addition,
while one variant of non-amnestic MCI involves executive dysfunction, such dysfunction
need not be due to ACC involvement at all but may instead be associated with other
frontal regions involved in EF, such as the dorsolateral prefrontal cortex (dLPFC; Lezak,
Howieson, & Loring, 2004; Pa et al., 2008). One study examining the dLPFC in MCI
patients using fMRI and an attentional control task found that MCI patients had higher
levels of activity in the dLPFC compared to controls (Rosano et al., 2005). With
increasing task difficulty, however, the controls preferentially recruited the dLPFC and
the ACC, while MCI patients recruited the posterior cingulate. The authors suggested that
the dLPFC may be affected early on in the course of MCI and suggest that changes in
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neural networks underlying EF may precede other symptoms in AD development
(Rosano et al., 2005).
Additionally, it may be that the executive dysfunction found in some cases of
non-amnestic MCI is due to damage in other brain regions with relative sparing of the
frontal lobes. For instance, intact basic attentional abilities, among other things, are
necessary for optimal performance on executive functioning tasks. According to the dualattentional theory, attention is subserved by a fronto-parietal network which includes the
dorsal and ventral posterior parietal cortex (PPC; e.g., Behrmann et al., 2004; Corbetta &
Shulman, 2002; Corbetta, Patel, & Shulman, 2008). It may be that non-amnestic MCI
patients with executive dysfunction are impaired in the parietal brain regions underlying
basic attention, such as the PPC. While much research has examined the involvement of
parietal areas in memory impairment in MCI and AD (see Uncapher & Wagner, 2009, for
a review), more research is needed to examine the involvement of parietal areas in
executive dysfunction found in these populations as well.
An additional possibility regarding hippocampal volumes is that white matter
instead of gray matter changes may account for memory impairment in MCI. Some
studies have reported that the memory deficits found in amnestic MCI are due to a
disruption of white matter tracts found in the parahippocampal gyrus, including the
perforant path (e.g., Huang, Friedland, & Auchus, 2007; Stoub et al., 2006). It is possible
that the amnestic MCI patients in the current study suffered from changes in the
parahippocampal white matter, which would negatively impact memory performance, in
the absence of significant hippocampal atrophy. Other studies using diffusion-tensor
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imaging have found white matter changes in the fibers which connect the medial
temporal lobe, including the hippocampus, to the cingulate (e.g., Zhang et al., 2007). In
sum, these studies suggest that white matter changes are also important to consider in
MCI, and may be present in the absence of gray matter changes.
Also, studies of atrophy in amnestic MCI have frequently reported atrophy in the
entorhinal cortex (EC), a structure intimately related to the hippocampus and important
for memory (Mesulam, 2000). Some studies have suggested that changes in the EC
precede those in the hippocampus (e.g., de Toledo-Morrell, Goncharova, Dickerson,
Wilson, & Bennett, 2008; Mesulam, 2000; Ries et al., 2008). Thus, the amnestic MCI
patients in the current study may have exhibited atrophy in the EC with sparing of the
hippocampus, particularly if the patients were early in their disease course.
However, because of the large body of evidence finding hippocampal
involvement in amnestic MCI, it is likely that the current study’s null findings are also
attributable to methodological issues. It is possible that this study’s relatively small
sample size may have reduced the power to detect significant effects. Additionally, as is
typical of samples collected through medical centers affiliated with educational
institutions, this study’s sample was generally a highly educated group. Education has
been found to be a protective factor against cognitive decline (see Stern, 2009, for a
review). Such associations between education and lower risk for cognitive decline have
been attributed to the possibility that those receiving more years of education may have
more cognitive reserve (Stern, 2009). Cognitive reserve is thought to allow a person to
maintain cognitive performance despite increases in neuropathology, and is hypothesized
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to operate through two processes (Stern, 2009). The first is neural reserve, which
represents individual differences in the “efficiency, capacity, or flexibility” (Stern, 2009,
p. 2016) of neural networks which mediate performance on a certain cognitive task
(Stern, 2009). The second process is neural compensation, which refers to the ability of
someone with more cognitive reserve to recruit additional brain regions or networks
during task performance to off-set decline (Stern, 2009). Thus, individuals with high
cognitive reserve can off-set potential cognitive decline from increasing neuropathology
by employing neural reserve and compensation (Stern, 2009). Based upon this theory of
cognitive reserve, an older adult with high cognitive reserve is expected to have more
neuropathology than an older adult with the same level of cognitive functioning who has
less cognitive reserve (Stern, 2009). Following this prediction, it is possible that the
control subjects in the current study, who had high educational attainment (a proxy for
cognitive reserve), actually exhibited atrophy in the hippocampus and ACC but did not
meet criteria for MCI through the action of cognitive reserve. If control subjects did in
fact exhibit brain atrophy, this contamination of the cognitively intact sample would
prevent the detection of differences in ROI volumes between cognitively intact and MCI
groups.
It is also possible that the MCI patients in this study’s sample were less severe
cases of MCI than in other studies. Because severity has been found to be positively
correlated with brain atrophy in MCI and dementia patients (e.g., Iacono et al., 2008;
Ruidavets et al., 2007; Whitwell et al., 2008), it may be that a less severe sample would
not yet display the brain atrophy seen in more advanced cases of MCI, leading to null
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findings. In fact, one longitudinal study examined patients with amnestic MCI whose
diagnosis remained stable and amnestic MCI patients who later converted to AD. While
the patients who converted to AD showed significantly smaller volumes in several brain
regions than controls, MCI patients who remained stable showed no gray matter
differences when compared to controls (Whitwell et al., 2008). Several other studies have
also reported hippocampal atrophy to be predictive of conversion from MCI to AD (e.g.,
DeCarli et al., 2007; Fleisher et al., 2008; Karas et al., 2008). Thus, if this study’s
participants were less severe or were less likely to convert to dementia, differences in
hippocampal volumes between these patients and cognitively normal controls would be
negligible.
Finally, another possible explanation for the lack of significant findings in this
study lies in the division of patients into amnestic and non-amnestic MCI categories. As
discussed earlier, MCI patients can be impaired in either one cognitive domain or
multiple cognitive domains. Memory impairment trumps impairment in all other
domains; thus, if a person is impaired in memory in addition to non-memory domains,
they are automatically categorized as an amnestic MCI patient. This means that multipledomain amnestic MCI patients may in fact also be impaired in executive functioning. The
presence of patients with executive dysfunction in this study’s amnestic MCI sample
would dilute any differences in ACC volumes between amnestic and non-amnestic MCI
groups. Similarly, patients with non-amnestic MCI may be impaired in domains other
than executive functioning, such as language or visuospatial processing. Such lack of

66
homogeneity in the non-amnestic MCI sample may again dilute any ACC volume
differences between amnestic, non-amnestic, and cognitively normal controls.
Future research can address these limitations by examining ACC and
hippocampal volumes in amnestic and non-amnestic MCI patients with and without
executive dysfunction. Moreover, the inclusion of neuropsychological test scores would
allow an investigation of the relationship between cognitive functioning and ROI volume.
In this way, the relationship between performance on EF measures and ACC volume, for
example, can be directly assessed in this population. It may also be beneficial to include
an analysis of the EC as well as to examine white matter changes in parahippocampal
regions. Additionally, studies in this area should examine other frontal regions in addition
to the ACC, such as the dorsolateral prefrontal cortex. Functional imaging may be an
even more sensitive indicator of brain abnormalities than volumetric studies, as certain
ROIs may begin to function abnormally prior to any tissue loss. For instance, in a study
of amnestic and non-amnestic MCI patients using both structural MRI and PET, no
significant volumetric differences were found between amnestic MCI patients and
controls, yet PET imaging revealed significant hypoperfusion in medial temporal lobe
structures, including the hippocampus, in amnestic MCI patients compared to controls
(Jauhiainen et al., 2008). It may also be worthwhile to investigate the relative
contribution of frontal versus parietal involvement in MCI patients with executive
impairment. As discussed above, it may be that dysexecutive MCI is characterized not by
damage in frontal areas but rather damage in other areas which indirectly affect executive
functioning, such as the PPC (e.g., Behrmann et al., 2004; Corbetta & Shulman, 2002;
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Corbetta et al., 2008). Ultimately, longitudinal research is essential for determining
whether the atrophy rate in various ROIs differs across MCI subtypes and whether these
differences predict the type of dementia MCI patients eventually convert to.
Bearing in mind the limitations of this study, it nonetheless has several
implications for research on MCI. This study suggests that the ACC may not be involved
in non-amnestic MCI, although additional studies are needed to fully examine this
possibility. Should this finding be replicated by future work, it suggests that EF deficits
found in MCI occur through damage to a different area in the neural network underlying
EF, either within or beyond the frontal lobes. Because the lack of findings in this study
also leaves open the possibility that no specific brain region differentiates the subtypes of
MCI, it begs the question whether MCI subtypes are truly distinct. The nature of the
subtypes of MCI, and in particular whether they are pathways to the same or different
forms of dementia, has been a point of contention in the literature. While the current
study does not provide an answer to this debate, it does imply that the subtypes of MCI
may be more similar than previously believed.
In summary, the present study examined differences in hippocampal and ACC
volumes in cognitively intact patients and those with amnestic and non-amnestic MCI.
After controlling for the effects of premorbid IQ, education, and dementia severity, no
significant differences were found among participants in either ROI. While the
interpretation of these results is limited by a small, highly educated sample and the
possibility of executive dysfunction being present in patients in both amnestic and nonamnestic groups, these findings still have important implications for the field. This study
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suggests that the ACC is not involved in non-amnestic MCI and that other areas in the
EF-neural network may instead be compromised. Furthermore, it is possible that no brain
regions exist that consistently differentiate the subtypes of MCI, which suggests the
possibility that the distinction between amnestic and non-amnestic MCI is invalid. Future
research in this area is necessary to further elucidate the nature of the subtypes of MCI
and their relationship to one another. Once a full understanding of MCI is achieved,
effective interventions targeting the cognitive decline seen in MCI and dementia can be
designed.
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